Unmeasured competing risk of death and NSAID-subtype heterogeneity in the assessment of NSAID use across coronary artery disease severity

Muhammad Shaheer Ahmad Baloch

Open source

DOI
10.1007/s00228-026-04190-9
Published
2026-09-24
Container
European Journal of Clinical Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-026-04190-9,
  title = {Unmeasured competing risk of death and NSAID-subtype heterogeneity in the assessment of NSAID use across coronary artery disease severity},
  author = {Muhammad Shaheer Ahmad Baloch},
  year = {2026},
  journal = {European Journal of Clinical Pharmacology},
  doi = {10.1007/s00228-026-04190-9},
  url = {https://doi.org/10.1007/s00228-026-04190-9}
}

RIS

TY  - JOUR
TI  - Unmeasured competing risk of death and NSAID-subtype heterogeneity in the assessment of NSAID use across coronary artery disease severity
AU  - Muhammad Shaheer Ahmad Baloch
PY  - 2026
JO  - European Journal of Clinical Pharmacology
DO  - 10.1007/s00228-026-04190-9
UR  - https://doi.org/10.1007/s00228-026-04190-9
ER  - 

APA

Baloch, M. S. A. (2026). Unmeasured competing risk of death and NSAID-subtype heterogeneity in the assessment of NSAID use across coronary artery disease severity. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-026-04190-9

Source records